New Rhein
Founded in 2010, New Rhein is a venture capital firm focused on healthcare therapeutics and medical devices. It invests in businesses that leverage proven products for new applications, such as new indications or dosage forms. The firm compiles syndicates of operationally-focused investors to support portfolio companies across development, regulatory, marketing, and manufacturing aspects.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Pennsylvania
Neuraptive Therapeutics
Series A in 2018
Neuraptive Therapeutics is a biotechnology company developing innovative therapeutics and medical products for treating peripheral nerve injuries. Its flagship product, AxoFuse, aids in nerve repair by preventing degeneration and limb atrophy. The company also offers surgical instruments like AxoTrim and AxoBond to facilitate nerve repairs. Neuraptive was founded in 2016 with headquarters in Lafayette, Colorado.
Neuraptive Therapeutics
Seed Round in 2017
Neuraptive Therapeutics is a biotechnology company developing innovative therapeutics and medical products for treating peripheral nerve injuries. Its flagship product, AxoFuse, aids in nerve repair by preventing degeneration and limb atrophy. The company also offers surgical instruments like AxoTrim and AxoBond to facilitate nerve repairs. Neuraptive was founded in 2016 with headquarters in Lafayette, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.